Zucali PA, et al. - In patients with advanced/recurrent thymoma (T) or thymic carcinoma (TC) previously treated with cisplatin-containing chemotherapy, researchers investigated the activity of everolimus. Based on the findings, it appeared that everolimus could induce durable disease control in a high percentage of these patients, albeit with a potential high risk of fatal pneumonitis.